drugset / Trial / NCT02009215

School-Based Treatment With ACT to Reduce Transmission

NCT02009215

RandomizedParallel-groupOpen-labelPrevention

Summary

We propose to evaluate the community-level impact of intermittent preventive treatment (IPT) for malaria in schoolchildren on clinical outcomes and malaria transmission, using a cluster-randomised design in Jinja, Uganda. Dihydroartemisinin-piperaquine (DP) will be administered to schoolchildren monthly for up to six rounds of treatment during one school year. Outcomes will be measured using surveys of communities, schoolchildren, and mosquito vectors. Our proposal also includes health service research to evaluate the potential feasibility of taking the programme to scale, which will guide future research and implementation of the intervention, and help shape policies in Uganda and elsewhere in Africa.

Timeline

Start
2014-02
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dihydroartemisinin-piperaquine Unknown 40 mg Oral
Subject Dihydroartemisinin-piperaquine Unknown 320 mg Oral

Indications